Anaergia Singapore Pte. Ltd. Signs Conditional Contract to Design and Build Biogas Facility in Jeju Island, South Korea
SINGAPORE & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc.'s ('Anaergia', the 'Company', 'us', or 'our') (TSX:ANRG) (OTCQX:ANRGF), subsidiary, Anaergia Singapore Pte. Ltd., has received a contract from New Jeju Bio Co. Ltd. ('New Jeju Bio') to design and build the Jeju Bio Energy Biogas Plant ('Facility'), to be constructed in Jeju Island, South Korea. The contract consists of a main agreement worth approximately C$30 million plus a supplement agreement valued at approximately C$10 million, and the company currently anticipates that the project will be completed in mid- to late-2027. The contract is subject to a number of routine conditions, including that the client arrange the financial close of this project.
'New Jeju Bio chose Anaergia for this project due to its proven ability to deliver integrated, complex solutions,' said Sae Hyun Cho, CEO of New Jeju Bio.
Share
This development represents an expansion of Anaergia's involvement, previously disclosed on September 3, 2024, when a Letter of Award for this Facility was announced. The increase in Anaergia's projected revenues from the amount disclosed at that time reflects both the expanded scope and the increased project size.
The Facility aims to convert approximately 54,000 tons per year of organic waste, including waste from slaughterhouses and undigested sludge from local sewage treatment plants, into about two (2) megawatts of renewable energy. The biogas produced will be used to power a combined heat and power (CHP) system, providing electricity and heat to support various operations, including digestion, pasteurization, evaporation, and digestate drying. Additionally, the wastewater generated will be treated and recycled on-site, adhering to strict discharge regulations, while significantly reducing greenhouse gas emissions and promoting waste recycling across Jeju Island.
'New Jeju Bio chose Anaergia for this project due to its proven ability to deliver integrated, complex solutions,' said Sae Hyun Cho, CEO of New Jeju Bio. 'Throughout the design process, we expanded our use of Anaergia's technologies to address the diverse organic waste streams generated on Jeju Island and optimally transform them into valuable resources.'
'Finalizing the contract with New Jeju Bio marks an even more significant achievement than we had previously envisioned,' said Assaf Onn, CEO of Anaergia. 'Not only is this a very significant project in a key new market, but it also clearly demonstrates how our industry-leading, integrated suite of technologies provides a proven, comprehensive solution for project developers seeking reliable, innovative organic waste to energy systems.'
About New Jeju Bio
New Jeju Bio Co Ltd is a developer of organic waste to energy and recycling projects leading to production of biogas and fertilizer in South Korea. Its mission is to support the 2021 Declaration of '2030 Waste Free Jeju.' It believes in creating environmental value through co-evolution of Jeju's natural environment and humanities. Founded with the principles of developing state of the art biogas facilities by integrating advanced and proven technologies, New Jeju Bio intends to be the leading biogas player not only in Jeju but also in South Korea.
About Anaergia
Anaergia is a pioneering technology company in the renewable natural gas (RNG) sector, with over 250 patents dedicated to converting organic waste into sustainable solutions such as RNG, fertilizer, and water. We are committed to addressing a significant source of greenhouse gases (GHGs) through cost-effective processes. Our proprietary technologies, combined with our engineering expertise and vast experience in facility design, construction, and operation, position Anaergia as a leader in the RNG industry. With a proven track record of delivering hundreds of innovative projects over the past decade, we are well-equipped to tackle today's critical resource recovery challenges through diverse project delivery methods. As one of the few companies worldwide offering an integrated portfolio of end-to-end solutions, we effectively combine solid waste processing, wastewater treatment, organics recovery, high-efficiency anaerobic digestion, and biomethane production. Additionally, we operate RNG facilities owned by both third parties and Anaergia. This comprehensive approach not only reduces environmental impact but also significantly lowers costs associated with waste and wastewater treatment while mitigating GHG emissions.
For further information please see: www.anaergia.com
Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects Anaergia's current expectations regarding future events. Forward-looking information is based on a number of assumptions, including, but not limited to counterparty contractual performance and its procurement of the financing that is a necessary condition to proceed with detailed engineering and construction of the Facility, the capability of the Company's technology and performance with respect to the project objectives, the sufficient sourcing of food waste, heat and power generation, and the sufficient production of digestate and recycled water for the project objectives. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company's control. Such risks and uncertainties include, but are not limited to, the factors discussed under 'Risk Factors' in the Company's annual information form for the fiscal year ended December 31, 2024, and under 'Risks and Uncertainties' in the Company's most recent management's discussion and analysis. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws. Additional information on these and other factors that could affect Anaergia's operations or financial results are included in Anaergia's reports on file with Canadian regulatory authorities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit
Industry Leader Highlights Innovations in Cyber Preparedness Training NASHVILLE, Tenn., June 09, 2025--(BUSINESS WIRE)--Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit, June 9–11 in National Harbor, MD. At the summit, Cloud Range will demonstrate its latest advancements, including the award-winning Range365™ platform—a fully managed, cloud-based cyber range with customizable IT and OT/ICS environments. Range365 strengthens security teams to engage in realistic attack scenarios, directly reducing cyber risk. Additionally, Cloud Range will showcase its Performance Portal, a comprehensive learning management system (LMS) providing detailed analytics on individual and team performance, enabling targeted, continuous skill development aligned to organizational needs. "The Gartner Summit is a pivotal event that brings together the brightest minds in cybersecurity," said Debbie Gordon, CEO and Founder of Cloud Range. "As cyber threats become increasingly sophisticated, it's clear that tools and tech stacks alone are not enough. From global enterprises to top universities, organizations must recognize that people—not just technology—are at the core of cyber defense. Our mission is to ensure SOC and incident response teams are always ready through immersive, real-world training programs that provide hands-on experience, build confidence, and help ensure resilience. Our presence at the summit underscores our commitment to advancing cyber defense capabilities across industries." Cloud Range's innovative approach has garnered significant recognition, including the 2025 SC Award for Best IT Security-Related Training Program and the 2025 Global InfoSec Award for Visionary Cybersecurity Training. These accolades and others reflect the company's dedication to providing cutting-edge solutions that address the evolving needs of cybersecurity professionals. Beyond enterprise solutions, Cloud Range is actively involved in shaping the future of cybersecurity education. Through collaborations with initiatives like IBM's Cyber Campus and partnerships with organizations such as Cyviz, Cloud Range is integrating its simulation technology into academic curricula, providing students with practical, real-world skills and experience to bridge the gap between theoretical knowledge and real-world application. It's a true redefinition of the student journey. For more information about Cloud Range's offerings or to schedule a demonstration at the Gartner Security & Risk Management Summit, visit: About Cloud Range Cloud Range is the first cyber Range-as-a-Service, delivering fully customizable cyberattack simulation training to prepare security teams for real-world threats. Trusted by enterprise SOCs, MSSPs, government agencies, higher education institutions, utilities, and critical infrastructure, Cloud Range helps organizations accelerate cyber defense skills and reduce risk. With Cloud Range's immersive, on-demand platform, customers can train teams, assess talent, onboard new hires, and upskill cybersecurity professionals—without needing costly physical labs or red teams. Recent recognition includes the 2025 SC Award for Best IT Security Training Program, the 2025 Global InfoSec Award for Visionary in Cybersecurity Training, the CISO Choice Award, and more. Stay ahead of threats with hands-on cyber readiness. Explore Cloud Range at View source version on Contacts Media Contact Leslie KesselringKesselring Communications for Cloud Rangeleslie@ 503-358-1012 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company's Integrated Savings Program, and access over 90 brand medication partnership offerings Cost-plus pricing is anchored on NADAC Starting July 1, all independent pharmacies will be opted out of GoodRx's Integrated Savings Program by default SANTA MONICA, Calif., June 09, 2025--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the industry challenges that independent community pharmacies face around complex reimbursement models and competitive pressures, Community Link leverages a cost-plus pricing model based on NADAC to provide predictable pricing and favorable economics. This announcement showcases GoodRx's commitment to helping independent pharmacies better manage pricing while continuing to provide consumers with affordable prices on their medications. "We know independent pharmacies are critical pillars in our communities that help millions of Americans access their medications and they need bespoke solutions to help address the industry problems they face," said Aaron Crittenden, President of Rx Marketplace at GoodRx. "GoodRx Community Link is the result of a multi-year journey to evolve the GoodRx business model and deliver solutions tailored to the specific needs of independent pharmacies. Ultimately, our goal with Community Link is to help improve the retail pharmacy business model and support a bright future for the sector." Community Link enables independent pharmacies to: Direct Contract with GoodRx: Leverages cost-plus pricing anchored on NADAC to provide independent pharmacies with direct control over pricing and favorable margins. A direct contract means the pricing relationship is entirely between GoodRx and the pharmacy, with no PBM involvement. Entering into a direct agreement with GoodRx does not waive a pharmacy's right to participate in ongoing litigation against GoodRx. Manage Participation in GoodRx's Integrated Savings Program (ISP): When a direct contract is signed, independent pharmacies will have the ability to opt-in to ISP as an additional benefit of working with GoodRx. Starting July 1, all independent pharmacies will be opted out of ISP by default. ISP participation may offer more favorable rates than traditional commercial insurance reimbursement. Access Over 90 Brand Medication Deals: A unique offering where the manufacturer buys down the price of a brand medication via GoodRx, making it more affordable for the consumer and economically beneficial for the pharmacy. Examples include Lantus, a Humira® biosimilar, and medical devices such as Dexcom. Starting today, independent pharmacies can use their NCPDP number to login to GoodRx Community Link and manage their relationship with GoodRx: To view a recording of the GoodRx Community Link webinar that was hosted last week, visit: For any questions, please reach out to: communitylink@ About GoodRx GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications. GoodRx periodically posts information that may be important to investors on its investor relations website at We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx's website regularly for important information, in addition to following GoodRx's press releases, filings with the Securities and Exchange Commission (the "SEC") and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx's website is not incorporated by reference into, and is not a part of, this press release. GoodRx Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated savings, convenience and accessibility; the expected benefits and value of GoodRx Community Link and our Integrated Savings Programs; and our plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. View source version on Contacts Media Contact press@ Sign in to access your portfolio
Business Wire
21 minutes ago
- Business Wire
PHINIA Makes Paris Air Show Debut, Signaling Strategic Entry into Aerospace Market
PARIS--(BUSINESS WIRE)-- PHINIA Inc. (NYSE:PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, has announced its inaugural presence at the world's most prestigious aerospace industry trade show, the Paris Air Show 2025. Taking place between 16-22 June at Le Bourget Exhibition Center in Paris, PHINIA's debut at the event marks a significant step in the company's expansion into the aerospace industry. PHINIA will be exhibiting in Hall 4, Stand E97, where it will showcase its advanced capabilities in complex component manufacturing well suited for advanced aerospace propulsion systems. Known for its deep heritage in fuel systems and combustion technologies for automotive and high-performance applications, PHINIA is bringing its expertise to meet the complex, fast-evolving needs of the aerospace industry. The company's attendance at the world's largest air and space exhibition underscores its commitment to becoming a long-term, high-value partner in the global aerospace supply chain. 'With a strong foundation in sub-micron manufacturing, precision fluid management, system integration, and alternative fuel combustion, we are well positioned to support both current and next-generation aerospace propulsion systems,' said Brady Ericson, President and Chief Executive Officer, PHINIA. 'Our debut at the Paris Air Show is a natural evolution of our capabilities and a clear signal that PHINIA is ready to contribute meaningfully to the future of flight.' Already trusted by leading aerospace manufacturers, PHINIA is currently delivering two production programs launching in 2025 and 2026, as well as an advanced development project for future aerospace applications. These aerospace programs are well aligned with PHINIA's current expertise. PHINIA has a global footprint and proven agility in fast-track development, as well as a dedicated aerospace product line team and production line. The company is actively pursuing additional opportunities across both military and civil aviation. Visit PHINIA at Paris Air Show – Hall 4, Stand E97 – to learn how we're powering a cleaner tomorrow for the aerospace industry. Visit for more information. About PHINIA PHINIA is an independent, market-leading, premium solutions and components provider, with over 100 years of manufacturing expertise and industry relationships and a strong brand portfolio that includes DELPHI ®, DELCO REMY ® and HARTRIDGE™. With over 12,500 employees across 43 locations in 20 countries, PHINIA is headquartered in Auburn Hills, Michigan, USA. Across commercial vehicles and industrial applications (medium-duty and heavy-duty trucks, buses and other off-highway construction, marine, agricultural and aerospace and defense), light commercial vehicles (vans and trucks) and light passenger vehicles (passenger cars, mini-vans, cross-overs and sport-utility vehicles), we develop fuel systems, electrical systems, and aftermarket solutions designed to keep combustion engines operating at peak performance, while at the same time investing in advanced technologies to unlock the potential of alternative fuels. By providing what the market needs today to become more efficient and sustainable, while also developing innovative products and solutions to contribute to lower carbon mobility, we are the partner of choice for a diverse array of customers – powering our shared journey toward a cleaner tomorrow. © 2025 PHINIA Inc. All Rights Reserved.
